BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 12670464)

  • 1. The variant form of hairy-cell leukaemia.
    Matutes E; Wotherspoon A; Catovsky D
    Best Pract Res Clin Haematol; 2003 Mar; 16(1):41-56. PubMed ID: 12670464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hairy cell leukemia-variant--a case report.
    Gupta K; Jasmina A; Malhotra P; Varma N; Vaiphei K; Vohra H; Varma S; Garewal G
    Indian J Pathol Microbiol; 2005 Jul; 48(3):387-9. PubMed ID: 16761764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hairy cell leukaemia-variant: Disease features and treatment.
    Matutes E; Martínez-Trillos A; Campo E
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):253-63. PubMed ID: 26614904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of hairy cell leukemia variant.
    Găman AM; Dobrea CM; Găman MA
    Rom J Morphol Embryol; 2015; 56(2):553-6. PubMed ID: 26193228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
    Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
    Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and molecular characteristics and prognosis of classical hairy cell leukemia and hairy cell leukemia variant].
    Wei C; Jin XX; Cai H; Wang X; Zhuang JL; Zhou DB
    Zhonghua Nei Ke Za Zhi; 2023 Apr; 62(4):416-421. PubMed ID: 37032137
    [No Abstract]   [Full Text] [Related]  

  • 7. The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes.
    Matutes E; Morilla R; Owusu-Ankomah K; Houliham A; Meeus P; Catovsky D
    Leuk Lymphoma; 1994; 14 Suppl 1():57-61. PubMed ID: 7820054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hairy cell leukemia-variant with cladribine.
    Tetreault SA; Robbins BA; Saven A
    Leuk Lymphoma; 1999 Oct; 35(3-4):347-54. PubMed ID: 10706459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab in the treatment of the variant of hairy cell leukaemia: a case report.
    Hadzi-Pecova L; Stojanovik A; Petrusevska G; Panovska I
    Prilozi; 2008 Dec; 29(2):355-60. PubMed ID: 19259059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyclonal B-cell lymphocytosis with features resembling hairy cell leukemia-Japanese variant.
    Machii T; Yamaguchi M; Inoue R; Tokumine Y; Kuratsune H; Nagai H; Fukuda S; Furuyama K; Yamada O; Yahata Y; Kitani T
    Blood; 1997 Mar; 89(6):2008-14. PubMed ID: 9058722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia.
    Cornet E; Delmer A; Feugier P; Garnache-Ottou F; Ghez D; Leblond V; Levy V; Maloisel F; Re D; Zini JM; Troussard X;
    Ann Hematol; 2014 Dec; 93(12):1977-83. PubMed ID: 24994538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A variant form of hairy cell leukemia resistant to alpha-interferon: clinical and phenotypic characteristics of 17 patients.
    Sainati L; Matutes E; Mulligan S; de Oliveira MP; Rani S; Lampert IA; Catovsky D
    Blood; 1990 Jul; 76(1):157-62. PubMed ID: 2364167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hairy cell leukemia and variant in Taiwan: report of a variant case and literature review.
    Hsieh YC; Chang ST; Chuang SS; Lu CL; Tsao CJ; Lin CN; Li CY
    Int J Clin Exp Pathol; 2011 Jan; 4(2):183-9. PubMed ID: 21326814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland.
    Robak T; Błasińska-Morawiec M; Błoński J; Hellmann A; Hałaburda K; Konopka L; Kotlarek-Haus S; Potoczek S; Hansz J; Dmoszyńska A; Urasiński I; Zdziarska B; Dwilewicz-Trojaczek J; Hołowiecki J; Skotnicki AB
    Eur J Haematol; 1999 Jan; 62(1):49-56. PubMed ID: 9918312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia.
    Hanson CA; Gribbin TE; Schnitzer B; Schlegelmilch JA; Mitchell BS; Stoolman LM
    Blood; 1990 Dec; 76(11):2360-7. PubMed ID: 1701669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hairy cell leukemia: current concepts.
    Cannon T; Mobarek D; Wegge J; Tabbara IA
    Cancer Invest; 2008 Oct; 26(8):860-5. PubMed ID: 18798068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. My treatment approach to hairy cell leukemia.
    Naik RR; Saven A
    Mayo Clin Proc; 2012 Jan; 87(1):67-76. PubMed ID: 22212971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnosis of hairy cell leukemia can be established by flow cytometric analysis of peripheral blood, even in patients with low levels of circulating malignant cells.
    Cornfield DB; Mitchell Nelson DM; Rimsza LM; Moller-Patti D; Braylan RC
    Am J Hematol; 2001 Aug; 67(4):223-6. PubMed ID: 11443633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined treatment with splenectomy and cladribine in hairy cell leukemia in Taiwan: a clinicopathologic study of 5 cases.
    Yu YB; Li CY; Chen CC; You JY; Chau WK; Hsu HC; Gau JP; Chen PM; Ho CH
    J Chin Med Assoc; 2007 Dec; 70(12):551-5. PubMed ID: 18194897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology of hairy-cell leukaemia.
    Bethel KJ; Sharpe RW
    Best Pract Res Clin Haematol; 2003 Mar; 16(1):15-31. PubMed ID: 12670462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.